In preclinical myocardial infarction models, isolated CD34+ cells were associated with improvements in overall myocardial performance and regional wall motion, and they showed potential in reducing fibrosis and increasing angiogenesis [76]. The gene discussed is CD34; the disease is myocardial infarction.